Our services cover the full lifecycle management of pharmaceutical equipment, from planning, procurement, installation and commissioning to daily operation and maintenance, fault repair, preventive maintenance, and technical upgrades. We also provide value-added services such as compliance verification, personnel training, and digital system construction to help pharmaceutical companies achieve efficient, stable, and compliant equipment operation.
GENO pharmaceutical technology has been deeply involved in the pharmaceutical field for many years. With its professional technology and rich experience, it provides pharmaceutical enterprises with an overall solution of pharmaceutical equipment covering the whole life cycle.
The plan takes compliance as the core, strictly abides by the requirements of the GMP, and combines the production process and equipment characteristics of different pharmaceutical enterprises to customize the design schemes of Cleanliness classification, air purification system adaptation, ventilation system optimization, etc., to ensure that the production environment meets the high standard requirements of drug production. From equipment selection, installation and commissioning to daily operation and maintenance, we provide one-stop services: accurately evaluate the production scene in the early stage and match the pharmaceutical equipment with strong adaptability; During the installation stage, strictly control the construction quality and ensure the stable operation of equipment; During the operation and maintenance period, a real-time monitoring mechanism is established to dynamically track the equipment performance and environmental indicators. At the same time, regular personnel operation training is carried out to improve the professional skills of employees.
With professional, efficient and customized services, GENO pharmaceutical technology helps pharmaceutical enterprises improve production efficiency, ensure drug quality, and build a solid backing for pharmaceutical production safety.
GENO Pharmaceutical Technology provides a one-stop integrated solution covering laboratory "design consulting + engineering installation + after-sales operation and maintenance" for biological laboratories, physical and chemical laboratories, animal room laboratories, P3 laboratories, etc. of medical institutions, disease control centers, universities, inspection and testing institutions. This includes overall planning and design consulting, implementation of decoration, HVAC, ventilation, electrical, water supply and drainage, special gas system engineering, construction of intelligent management platforms and safety management platforms for laboratories, production and installation of laboratory supporting furniture and equipment, and other services.
GENO Pharmatech implements the strategy of 'strong alliance and establishes in-depth cooperative relationships withmany senior design instiutes in the industry to complement each other's advantages Adhering to the "customer-cen-ered" service concept, the Company provides customers with professional technical services throughout the full lifecycleservices from concept to qualified facility, including project feasibility study, investment decision-making and projectimplementation management, with 17 years of experience and professional accumulation in the industry.
The EPC service for cleanroom projects covers the entire process: from preliminary requirement research, standard establishment and scheme design, to the procurement of core purification equipment and building decoration materials, to the construction of the main structure, purification system and auxiliary system, and finally to the completion of commissioning and testing, completion acceptance and personnel training, as well as providing one-stop services such as maintenance and upgrading in the later stage, to ensure the efficient and standard operation of the cleanroom.
Antibody production can be divided into three major stages: upstream (cell culture to harvest), downstream (purification to filling), and formulation. According to the process, a complete upstream and downstream process system can be provided for the preparation of denosumab, tocilizumab, rituximab, trastuzumab, etc.